DK0641327T3 - Nye alfa-mannosidase-inhibitorer - Google Patents

Nye alfa-mannosidase-inhibitorer

Info

Publication number
DK0641327T3
DK0641327T3 DK92918131T DK92918131T DK0641327T3 DK 0641327 T3 DK0641327 T3 DK 0641327T3 DK 92918131 T DK92918131 T DK 92918131T DK 92918131 T DK92918131 T DK 92918131T DK 0641327 T3 DK0641327 T3 DK 0641327T3
Authority
DK
Denmark
Prior art keywords
alpha
beta
novel alpha
mannosidase inhibitors
mannosidase
Prior art date
Application number
DK92918131T
Other languages
Danish (da)
English (en)
Inventor
Robert A Farr
Mohinder S Kang
Norton P Peet
Sai P Sunkara
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0641327T3 publication Critical patent/DK0641327T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
DK92918131T 1991-09-18 1992-08-10 Nye alfa-mannosidase-inhibitorer DK0641327T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors
PCT/US1992/006707 WO1993005781A1 (en) 1991-09-18 1992-08-10 Novel alpha-mannosidase inhibitors

Publications (1)

Publication Number Publication Date
DK0641327T3 true DK0641327T3 (da) 1999-09-13

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918131T DK0641327T3 (da) 1991-09-18 1992-08-10 Nye alfa-mannosidase-inhibitorer

Country Status (15)

Country Link
US (1) US5262425A (ja)
EP (1) EP0641327B1 (ja)
JP (1) JP3226173B2 (ja)
KR (1) KR100244012B1 (ja)
AT (1) ATE175960T1 (ja)
AU (1) AU659486B2 (ja)
CA (1) CA2116224C (ja)
DE (1) DE69228259T2 (ja)
DK (1) DK0641327T3 (ja)
ES (1) ES2127758T3 (ja)
FI (1) FI105270B (ja)
GR (1) GR3029745T3 (ja)
HU (1) HU216789B (ja)
NO (1) NO300372B1 (ja)
WO (1) WO1993005781A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
AU2477192A (en) 1993-04-27
FI941259A0 (fi) 1994-03-17
DE69228259T2 (de) 1999-06-02
FI941259A (fi) 1994-03-17
US5262425A (en) 1993-11-16
HU9400787D0 (en) 1994-06-28
EP0641327A1 (en) 1995-03-08
GR3029745T3 (en) 1999-06-30
EP0641327B1 (en) 1999-01-20
NO940972L (no) 1994-03-17
NO300372B1 (no) 1997-05-20
DE69228259D1 (de) 1999-03-04
CA2116224C (en) 2003-06-03
ATE175960T1 (de) 1999-02-15
AU659486B2 (en) 1995-05-18
EP0641327A4 (en) 1994-06-01
ES2127758T3 (es) 1999-05-01
JPH06510785A (ja) 1994-12-01
HUT70527A (en) 1995-10-30
JP3226173B2 (ja) 2001-11-05
KR100244012B1 (ko) 2000-03-02
CA2116224A1 (en) 1993-04-01
WO1993005781A1 (en) 1993-04-01
HU216789B (hu) 1999-08-30
NO940972D0 (no) 1994-03-17
FI105270B (fi) 2000-07-14

Similar Documents

Publication Publication Date Title
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
CO4290353A1 (es) Agonistas de estrogeno
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
BR9203707A (pt) Compostos,composicao,emprego de compostos,processo para a fotopolimerizacao de compostos e emprego de uma composicao
ES2117034T3 (es) Composicion para la limpieza de vidrio.
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
DE69516866D1 (de) Stereochemische wortmanninderivate
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
DK537389A (da) Glycosidase-inhibitoren salbostatin, dens fremstilling og anvendelse
NO932547L (no) Isoksazolederivater for behandling av irritabelt tarmsyndrom
NO923265D0 (no) Benzol(f)quinolinoner
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
DK0641327T3 (da) Nye alfa-mannosidase-inhibitorer
NO871809L (no) Smoeremidler og nye polyfluorerte forbindelser til bruk som additiver
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
NO911419D0 (no) Fremgangsmaate for fremstilling av alfa-mannosidase og fucosidase inhibitorer.
DE69126612D1 (de) Carbamate des indan-pyrrolidins
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
MX9305453A (es) Metodo para tratar infecciones virales.
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
PL292747A1 (en) Method of obtaining novel (-)-trans-4-(2-(n,n-diethylamine) ethoxyl)-cis-crane
IT9021113V0 (it) Attrezzo portatile per la disinfezione di oggetti
IT1231065B (it) Dispositivo per eseguire l'asportazione chirurgica di segmenti di organi, per esempio segmenti epatici.